# A Comprehensive Review Exploring Allergic Rhinitis With Nasal Polyps: Mechanisms, Management, and Emerging Therapies

## TL;DR

This paper reviews allergic rhinitis with nasal polyps, focusing on causes, treatments, and new therapies to improve patient outcomes.

## Contribution

The paper provides a comprehensive review of mechanisms, management, and emerging therapies for allergic rhinitis with nasal polyps.

## Key findings

- Immunological, genetic, and environmental factors contribute to allergic rhinitis and nasal polyps.
- Biologic agents and surgery are key treatments for managing these conditions.
- Emerging therapies like immunomodulators and precision medicine show promise.

## Abstract

Allergic rhinitis (AR) and nasal polyps (NP) are common inflammatory disorders of the upper airways that often coexist and significantly impact patients' quality of life. This comprehensive review explores the intricate relationship between AR and NP, elucidating the underlying mechanisms, clinical manifestations, and management strategies. Immunological mechanisms, genetic predispositions, and environmental factors contribute to the development and progression of both conditions. Pharmacological therapies, including intranasal corticosteroids and biologic agents, are cornerstone treatments for managing AR with NP. At the same time, surgical interventions such as functional endoscopic sinus surgery (FESS) may be necessary in refractory cases. Emerging therapies, including immunomodulatory agents and precision medicine approaches, hold promise in improving treatment outcomes. A multidisciplinary approach, personalized treatment plans, and patient education are essential for optimizing clinical practice. Future research should focus on identifying novel therapeutic targets, conducting large-scale clinical trials, exploring precision medicine approaches, and investigating the role of the microbiome. Addressing these research priorities and implementing evidence-based treatment strategies can improve outcomes for patients with AR and NP.